Page 65 - மூலோபாய முயற்சிகள் பொது வாழ்க்கைத்தொழில்கள் ஹென்றி அகன்ற News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மூலோபாய முயற்சிகள் பொது வாழ்க்கைத்தொழில்கள் ஹென்றி அகன்ற. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மூலோபாய முயற்சிகள் பொது வாழ்க்கைத்தொழில்கள் ஹென்றி அகன்ற Today - Breaking & Trending Today

SSG's Strategic Move into Tokyo Cements Their Status as APAC's B2B [...]


12 gennaio 2021 07:42
Fonte: Adnkronos
#economia-e-finanza
CEO & President Michael Whife  honored and humbled  by the privilege to bring innovative marketing solutions to the region
TOKYO and DENVER, Jan. 12, 2021 /PRNewswire/ Selling Simplified Group, Inc. (SSG), announced today the opening of its Tokyo, Japan office, marking the company s 11th location in Asia Pacific and further establishing the company as the APAC region s B2B demand gen leader.
Michael Whife, SSG s CEO and President, said of the opening, We re truly honored and humbled to have a place on Japan s B2B stage, and we look forward to serving Japan s B2B leaders with the most innovative demand generation technology on the market. ....

United States , Michael Whife , Asia Pacific , Prnewswire Selling Simplified Group Inc , Simplified Group , Ssg S , Apac S , ஒன்றுபட்டது மாநிலங்களில் , ஆசியா பெஸிஃபிக் , எளிமைப்படுத்தப்பட்டது குழு , ஸ்ஸ்க் கள் , ஆபாச கள் ,

Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies


(2)
Collaboration focuses on up to three types of lung and gastrointestinal (GI) cancers
Latest in a series of strategic acquisitions and partnerships that strengthens Boehringer Ingelheim s position in the cancer vaccine and T-cell engager spaces
Agreement and partnership with Boehringer Ingelheim provides additional validation of Enara Bio s EDAPT platform and Dark Antigen discovery work and supports ongoing cell therapy based therapeutic approach
Boehringer Ingelheim and Enara Bio, today announced that they have entered into a strategic collaboration and licensing agreement to research and develop novel targeted cancer immunotherapies, leveraging Enara Bio s Dark Antigen discovery platform. This new collaboration combines Boehringer Ingelheim s approach to tackle cancer through pairing leading science with innovative immune-oncology platforms, such as oncolytic viruses and cancer vaccines, with Enara Bio s expertise in cancer antigen identification. The aim is t ....

Frazer Hall , Enara Bio , Boehringer Ingelheim , Jonathon Sedgwick , Linda Ruckel , Kevin Pojasek , Reinhard Malin , Nathaniel Dahan , Citigate Dewe Rogerson , Cancer Immunology Immune Modulation Research , Dark Antigen Platform Technology , Boehringer Ingelheim Corporate Center Gmb , Head Of Communications Innovation Unit , Dark Antigen , Senior Vice President , Global Head , Dark Antigens , T Cell Receptor , Communications Innovation Unit , Ingelheim Corporate Center Gmbh , Associate Director , Corporate Reputation , Bio Limited , Dewe Rogerson , ஃப்ரேசர் மண்டபம் , எனரா உயிர் ,

ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Strategic Priorities for 2021


ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Strategic Priorities for 2021
TORONTO and CAMBRIDGE, Mass., Jan. 12, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today an outline of its strategic priorities and action plan for 2021.
The priorities for 2021 fall into four key areas:
Near term focus on rare neurodegenerative diseases, especially ALS
Use of proprietary platform to support portfolio expansion
PMN310 antibody lead program for Alzheimer s disease
COVID-19, further progress on serological assays
Rare disease. ProMIS has made significant progress in the rare disease field in 2020 and we plan to focus most of our R & D efforts in the near term on further advancing our programs selectively targeting toxic misfolded pro ....

United Kingdom , United States , David Wishart , Twitterand Linkedin , Nicholas Rigopulos , Eli Lilly , Epitopes Dses , University Of Alberta , Toronto Stock Exchange , Promis Neurosciences Inc , Advisory Committee , Disease Specific Epitopes , Nature Medicine , Investor Relations , Neuro Sciences , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , டேவிட் விருப்பம் , எலி லில்லி , பல்கலைக்கழகம் ஆஃப் ஆல்பர்ட்டா , டொராண்டோ ஸ்டாக் பரிமாற்றம் , ப்ரோமிச் நரம்பியல் இன்க் , இயற்கை மருந்து , முதலீட்டாளர் உறவுகள் , நரம்பியல் அறிவியல் ,

Waratah Capital Advisors: Lithium Royalty Corp Announces Additional Capital Raise and Strategic Investors


Waratah Capital Advisors: Lithium Royalty Corp Announces Additional Capital Raise and Strategic Investors
TORONTO, ON / ACCESSWIRE / January 12, 2021 /
Lithium Royalty Corp LRC is pleased to announce that it has closed on US $70,669,843 of additional capital. As part of this raise, the Company is excited to welcome
Riverstone Holdings LLC as a strategic investor in the Company. Riverstone Holdings LLC is a New York-based leading private markets asset management firm dedicated to real assets investing primarily in energy, power and infrastructure.
Altius Minerals Corporation (TSX:ALS), a founding strategic investor in LRC, has made an additional investment in the Company. Altius Minerals Corporation is a St. John s-based diversified materials royalty investor, renewable power royalty investor and project generator. ....

New York , United States , City Of , United Kingdom , Fernie Ortiz , Jason Landau , Matt Juneau , Robert Tichio , Mark Wellings , Jeannine Li Chong , Kostenloser Wertpapierhandel , Constantine Karayannopoulos , Mark Raguz , Blair Levinsky , Adventus Mining Corporation , Lithium Royalty Corp , Goldman Sachs , Riverstone Holdings , Summerhill Resorts Ltd , Contact Gold Corp , Gold Corp , Lassonde Mineral Engineering Program , University Of Toronto , Waratah Capital Advisors Ltd , University Of Chicago , Investment Committee ,